Am J Gastroenterol

1. MIYOSHI Y, Nishio A, Tatsumi N, Yoshida Y, et al
   Ciliated Hepatic Foregut Cyst with Clustered Echogenic Foci: An Incidental Finding on Health Screening.
   Am J Gastroenterol. 2026 Mar 6. doi: 10.14309/ajg.0000000000003993.
   

   >> Share

   
   
2. YOHEI H, Sakaue T, Yoshimura S, Takedatsu H, et al
   A Continuous Metallic Stream: Endoscopic Salvage of Migrated Hepatic Artery Coils.
   Am J Gastroenterol. 2026 Mar 5. doi: 10.14309/ajg.0000000000003989.
   

   >> Share

   
   
3. BAJAJ JS, Jakab SS, Jesudian AB, Rahimi RS, et al
   ACG Clinical Guideline: Hepatic Encephalopathy.
   Am J Gastroenterol. 2026;121:588-618.
   

   >> Share

   
   

   
   Anticancer Res

4. TSUJI M, Kobayashi K, Kawakami K, Fukuda N, et al
   Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy.
   Anticancer Res. 2026;46:1651-1659.
   

   >> Share

   
   
5. MAIMON O, Nisman B, Ben-David I, Kuznetz A, et al
   Autologous Tumor Vaccination in Melanoma and Colon Cancer Patients With Recurrent Liver Metastases: A Case Series.
   Anticancer Res. 2026;46:1569-1575.
   

   >> Share

   
   

   
   BMC Cancer

6. ZHANG Q, Pang C, Song L, Liu Z, et al
   Identification and validation of an ultrasound-based interpretable machine learning model for the preoperative evaluation of microvascular invasion in patients with hepatocellular carcinoma.
   BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15828.
   

   >> Share

   
   

   
   BMC Gastroenterol

7. LI T, Zhao H, Dong C, Song Y, et al
   Comparison of the efficacy of transarterial chemoembolization combined with radiofrequency ablation or sintilimab and bevacizumab for unresectable hepatocellular carcinoma.
   BMC Gastroenterol. 2026 Mar 3. doi: 10.1186/s12876-026-04672.
   

   >> Share

   
   
8. SUN X, Wang X, Younas A, Wang S, et al
   Creatinine-to-body weight ratio as an independent predictor of hepatic steatosis severity in metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.
   BMC Gastroenterol. 2026 Mar 4. doi: 10.1186/s12876-026-04692.
   

   >> Share

   
   
9. YAO D, Pan J
   Development and validation of a prognostic model for cirrhotic patients after endoscopic variceal ligation.
   BMC Gastroenterol. 2026 Mar 3. doi: 10.1186/s12876-026-04697.
   

   >> Share

   
   
10. LV S, Feng H, Xu T, Tian H, et al
    Gastrointestinal bleeding risk in cirrhotic portal vein thrombosis: focus on thrombus extension to superior mesenteric vein.
    BMC Gastroenterol. 2026 Mar 3. doi: 10.1186/s12876-026-04710.
    

    >> Share

    
    

    
    Dig Dis Sci

11. RANGWANI S, Ying X, Jesudian AB
    From Hepatic Encephalopathy to Physiologic Reserve: Rifaximin's Second Act in Cirrhosis.
    Dig Dis Sci. 2026 Mar 2. doi: 10.1007/s10620-026-09790.
    

    >> Share

    
    
12. TANG S, Chen H
    Regulatory Role of Ribosome Biogenesis-Related Genes in Hepatocellular Carcinoma Prognosis and Construction of a Risk Prediction Model.
    Dig Dis Sci. 2026 Mar 3. doi: 10.1007/s10620-026-09787.
    

    >> Share

    
    
13. MIRONOVA M, Zaiman Z, Samuel MC, Gichoya JW, et al
    Real World Performance of the Model for End-Stage Liver Disease Score Across Different Races and Ethnicities.
    Dig Dis Sci. 2026;71:643-650.
    

    >> Share

    
    

    
    Endoscopy

14. LIN X, Cheng W, Qiu X, Sun J, et al
    Application of the novel peroral choledochoscope in hepatolithiasis after liver transplantation.
    Endoscopy. 2026;58.
    

    >> Share

    
    

    
    Eur Radiol

15. KEERTHIVASAN MB, Toner B, Galons JP, Johnson K, et al
    Diagnosing abdominal neoplasms using a T2 mapping radial turbo spin-echo technique with partial volume correction.
    Eur Radiol. 2026;36:2209-2218.
    

    >> Share

    
    

    
    Gastrointest Endosc

16. JIRAPINYO P, Papke DJ, Garcia-Tsao G, Ryou M, et al
    Endoscopic Gastric Remodeling and Its Histologic Impact on Metabolic Dysfunction-associated Steatohepatitis: A 12-month Prospective Study.
    Gastrointest Endosc. 2026 Mar 3:S0016-5107(26)00155.
    

    >> Share

    
    

    
    Hepatology

17. ZHIXING L, Liu S, Yu H, Yuxi L, et al
    Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.
    Hepatology. 2026 Mar 4. doi: 10.1097/HEP.0000000000001735.
    

    >> Share

    
    
18. GAWRIEH S, Lake JE, Debroy P, Sjoquist JA, et al
    Erratum: Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.
    Hepatology. 2026 Mar 4. doi: 10.1097/HEP.0000000000001717.
    

    >> Share

    
    

    
    J Hepatol

19. YU X, Sarabia S, Urbicain M, Somvanshi S, et al
    Asynchronous Transitions from High-Risk Hepatoblastoma to Carcinoma.
    J Hepatol. 2026 Feb 28:S0168-8278(26)00117-0. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
20. BHOORI S, Rivoltini L, Pinato DJ, Bellia V, et al
    Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL).
    J Hepatol. 2026 Feb 26:S0168-8278(26)00084-X. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    

    
    N Engl J Med

21. SHI GM, Huang XY, Liang F, Liang X, et al
    Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.
    N Engl J Med. 2026;394:983-995.
    

    >> Share

    
    

    
    PLoS One

22. LIU F, Zhao Y, Zhu D, Wang J, et al
    Mechanistic insights into triclosan-induced hepatotoxicity: A network toxicology and molecular docking approach.
    PLoS One. 2026;21:e0333244.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

23. LIANG X, Li L, Wang Y, Lu S, et al
    US Molecular Imaging of Glypican-3 Expression in Hepatocellular Carcinoma Using Targeted Biosynthetic Gas Vesicles.
    Radiol Imaging Cancer. 2026;8:e250480.
    

    >> Share

    
    
24. LIANG X, Li L, Wang Y, Lu S, et al
    A Look Behind the Paper: Glypican-3-targeted US Molecular Imaging of Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e260003.
    

    >> Share

    
    
25. XU J
    Molecular Imaging of Hepatocellular Carcinoma with Third-Generation US Contrast Agents: Toward Clinical Translation.
    Radiol Imaging Cancer. 2026;8:e260025.
    

    >> Share

    
    
26. ZHANG HH, Tan XZ
    Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250444.
    

    >> Share

    
    
27. SIDDIQI NS
    TACE with Lenvatinib and Pembrolizumab in Unresectable, Nonmetastatic Hepatocellular Carcinoma: Results from the LEAP-012 Trial.
    Radiol Imaging Cancer. 2026;8:e269003.
    

    >> Share

    
    
28. HUANG Z, Dong F
    From Precise Segmentation to Scalable Annotation: A Critical Step Toward Clinical Translation of Multisequence MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e260068.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share